Novartis Investigative Site

Romford, Essex RM7 0AG

1 studies enrolling now · 2 studies all time

What they study most

Heart Failure With Reduced Ejection Fraction, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early